nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—UGT1A9—Irinotecan—hematologic cancer	0.042	0.0696	CbGbCtD
Hydromorphone—PTGS1—Bortezomib—hematologic cancer	0.0381	0.0631	CbGbCtD
Hydromorphone—PTGS1—Thalidomide—hematologic cancer	0.0332	0.055	CbGbCtD
Hydromorphone—PTGS1—Ifosfamide—hematologic cancer	0.0292	0.0484	CbGbCtD
Hydromorphone—PTGS1—Imatinib—hematologic cancer	0.0279	0.0463	CbGbCtD
Hydromorphone—CYP2C9—Bexarotene—hematologic cancer	0.025	0.0415	CbGbCtD
Hydromorphone—CYP2D6—Lomustine—hematologic cancer	0.0213	0.0352	CbGbCtD
Hydromorphone—CYP2C9—Idarubicin—hematologic cancer	0.0207	0.0344	CbGbCtD
Hydromorphone—CYP2D6—Idarubicin—hematologic cancer	0.019	0.0314	CbGbCtD
Hydromorphone—CYP2D6—Hydroxyurea—hematologic cancer	0.0161	0.0267	CbGbCtD
Hydromorphone—CYP2C9—Bortezomib—hematologic cancer	0.0153	0.0254	CbGbCtD
Hydromorphone—CYP3A4—Bexarotene—hematologic cancer	0.0145	0.0241	CbGbCtD
Hydromorphone—CYP2D6—Bortezomib—hematologic cancer	0.014	0.0232	CbGbCtD
Hydromorphone—PTGS1—Etoposide—hematologic cancer	0.014	0.0231	CbGbCtD
Hydromorphone—CYP3A4—Lomustine—hematologic cancer	0.0135	0.0224	CbGbCtD
Hydromorphone—CYP3A4—Busulfan—hematologic cancer	0.0135	0.0224	CbGbCtD
Hydromorphone—CYP2C9—Thalidomide—hematologic cancer	0.0134	0.0221	CbGbCtD
Hydromorphone—CYP2C9—Teniposide—hematologic cancer	0.0127	0.0211	CbGbCtD
Hydromorphone—CYP3A4—Thiotepa—hematologic cancer	0.0121	0.02	CbGbCtD
Hydromorphone—CYP2C9—Ifosfamide—hematologic cancer	0.0118	0.0195	CbGbCtD
Hydromorphone—CYP2C9—Imatinib—hematologic cancer	0.0112	0.0186	CbGbCtD
Hydromorphone—CYP2D6—Imatinib—hematologic cancer	0.0103	0.017	CbGbCtD
Hydromorphone—CYP2C9—Nilotinib—hematologic cancer	0.0102	0.0169	CbGbCtD
Hydromorphone—CYP3A4—Methoxsalen—hematologic cancer	0.00938	0.0155	CbGbCtD
Hydromorphone—CYP2D6—Nilotinib—hematologic cancer	0.00934	0.0155	CbGbCtD
Hydromorphone—CYP2D6—Vinorelbine—hematologic cancer	0.00926	0.0153	CbGbCtD
Hydromorphone—CYP3A4—Bortezomib—hematologic cancer	0.00892	0.0148	CbGbCtD
Hydromorphone—CYP3A4—Daunorubicin—hematologic cancer	0.00853	0.0141	CbGbCtD
Hydromorphone—CYP3A4—Cytarabine—hematologic cancer	0.00752	0.0125	CbGbCtD
Hydromorphone—CYP3A4—Teniposide—hematologic cancer	0.00741	0.0123	CbGbCtD
Hydromorphone—CYP3A4—Ifosfamide—hematologic cancer	0.00684	0.0113	CbGbCtD
Hydromorphone—CYP3A4—Imatinib—hematologic cancer	0.00653	0.0108	CbGbCtD
Hydromorphone—CYP3A4—Ruxolitinib—hematologic cancer	0.00615	0.0102	CbGbCtD
Hydromorphone—CYP3A4—Nilotinib—hematologic cancer	0.00594	0.00984	CbGbCtD
Hydromorphone—CYP3A4—Vinorelbine—hematologic cancer	0.00589	0.00976	CbGbCtD
Hydromorphone—CYP2C9—Cisplatin—hematologic cancer	0.00572	0.00948	CbGbCtD
Hydromorphone—CYP2D6—Vinblastine—hematologic cancer	0.00571	0.00945	CbGbCtD
Hydromorphone—CYP3A4—Triamcinolone—hematologic cancer	0.00538	0.00892	CbGbCtD
Hydromorphone—CYP3A4—Dasatinib—hematologic cancer	0.00525	0.0087	CbGbCtD
Hydromorphone—CYP3A4—Mitoxantrone—hematologic cancer	0.00518	0.00859	CbGbCtD
Hydromorphone—CYP2C9—Dexamethasone—hematologic cancer	0.00462	0.00766	CbGbCtD
Hydromorphone—CYP3A4—Betamethasone—hematologic cancer	0.00462	0.00766	CbGbCtD
Hydromorphone—CYP3A4—Prednisolone—hematologic cancer	0.00456	0.00755	CbGbCtD
Hydromorphone—CYP3A4—Prednisone—hematologic cancer	0.0043	0.00713	CbGbCtD
Hydromorphone—CYP2D6—Dexamethasone—hematologic cancer	0.00423	0.007	CbGbCtD
Hydromorphone—CYP3A4—Irinotecan—hematologic cancer	0.00408	0.00676	CbGbCtD
Hydromorphone—CYP3A4—Vinblastine—hematologic cancer	0.00363	0.00601	CbGbCtD
Hydromorphone—CYP3A4—Vincristine—hematologic cancer	0.00357	0.00591	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—hematologic cancer	0.00351	0.00581	CbGbCtD
Hydromorphone—CYP3A4—Etoposide—hematologic cancer	0.00327	0.00542	CbGbCtD
Hydromorphone—CYP3A4—Dexamethasone—hematologic cancer	0.00269	0.00445	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—hematologic cancer	0.00223	0.00369	CbGbCtD
Hydromorphone—Naloxone—CREB1—hematologic cancer	0.00141	0.373	CrCbGaD
Hydromorphone—Naltrexone—UGT1A1—hematologic cancer	0.000682	0.18	CrCbGaD
Hydromorphone—Morphine—UGT1A1—hematologic cancer	0.00042	0.111	CrCbGaD
Hydromorphone—Codeine—SLC22A1—hematologic cancer	0.000418	0.11	CrCbGaD
Hydromorphone—Naloxone—ESR1—hematologic cancer	0.000274	0.0725	CrCbGaD
Hydromorphone—Naltrexone—ABCB1—hematologic cancer	0.00016	0.0422	CrCbGaD
Hydromorphone—Naloxone—ALB—hematologic cancer	0.000122	0.0323	CrCbGaD
Hydromorphone—Naloxone—ABCB1—hematologic cancer	0.000116	0.0308	CrCbGaD
Hydromorphone—Morphine—ABCB1—hematologic cancer	9.83e-05	0.026	CrCbGaD
Hydromorphone—Dextromethorphan—ABCB1—hematologic cancer	8.25e-05	0.0218	CrCbGaD
Hydromorphone—Anorexia—Prednisone—hematologic cancer	2.1e-05	6.69e-05	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—hematologic cancer	2.09e-05	6.68e-05	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—hematologic cancer	2.09e-05	6.67e-05	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—hematologic cancer	2.09e-05	6.66e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Betamethasone—hematologic cancer	2.08e-05	6.64e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Dexamethasone—hematologic cancer	2.08e-05	6.64e-05	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—hematologic cancer	2.08e-05	6.63e-05	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—hematologic cancer	2.08e-05	6.63e-05	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—hematologic cancer	2.08e-05	6.63e-05	CcSEcCtD
Hydromorphone—Tension—Epirubicin—hematologic cancer	2.07e-05	6.6e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.06e-05	6.59e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.06e-05	6.59e-05	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—hematologic cancer	2.06e-05	6.59e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Triamcinolone—hematologic cancer	2.05e-05	6.54e-05	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—hematologic cancer	2.05e-05	6.53e-05	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—hematologic cancer	2.04e-05	6.5e-05	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—hematologic cancer	2.03e-05	6.49e-05	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—hematologic cancer	2.03e-05	6.48e-05	CcSEcCtD
Hydromorphone—Dizziness—Etoposide—hematologic cancer	2.03e-05	6.47e-05	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—hematologic cancer	2.03e-05	6.47e-05	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—hematologic cancer	2.02e-05	6.46e-05	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—hematologic cancer	2.02e-05	6.46e-05	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—hematologic cancer	2.02e-05	6.44e-05	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—hematologic cancer	2.02e-05	6.43e-05	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—hematologic cancer	2.01e-05	6.41e-05	CcSEcCtD
Hydromorphone—Urticaria—Dexamethasone—hematologic cancer	2.01e-05	6.4e-05	CcSEcCtD
Hydromorphone—Urticaria—Betamethasone—hematologic cancer	2.01e-05	6.4e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2e-05	6.39e-05	CcSEcCtD
Hydromorphone—Dizziness—Prednisolone—hematologic cancer	2e-05	6.39e-05	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—hematologic cancer	2e-05	6.39e-05	CcSEcCtD
Hydromorphone—Asthenia—Triamcinolone—hematologic cancer	2e-05	6.37e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Betamethasone—hematologic cancer	2e-05	6.37e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Dexamethasone—hematologic cancer	2e-05	6.37e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Dexamethasone—hematologic cancer	2e-05	6.37e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Betamethasone—hematologic cancer	2e-05	6.37e-05	CcSEcCtD
Hydromorphone—Nausea—Cisplatin—hematologic cancer	1.99e-05	6.35e-05	CcSEcCtD
Hydromorphone—Insomnia—Prednisone—hematologic cancer	1.99e-05	6.35e-05	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—hematologic cancer	1.99e-05	6.34e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Prednisone—hematologic cancer	1.97e-05	6.3e-05	CcSEcCtD
Hydromorphone—Pruritus—Triamcinolone—hematologic cancer	1.97e-05	6.28e-05	CcSEcCtD
Hydromorphone—Cough—Methotrexate—hematologic cancer	1.96e-05	6.27e-05	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—hematologic cancer	1.96e-05	6.26e-05	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—hematologic cancer	1.95e-05	6.24e-05	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—hematologic cancer	1.95e-05	6.23e-05	CcSEcCtD
Hydromorphone—Vomiting—Etoposide—hematologic cancer	1.95e-05	6.23e-05	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—hematologic cancer	1.95e-05	6.22e-05	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—hematologic cancer	1.95e-05	6.22e-05	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—hematologic cancer	1.94e-05	6.18e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Prednisone—hematologic cancer	1.94e-05	6.18e-05	CcSEcCtD
Hydromorphone—Rash—Etoposide—hematologic cancer	1.93e-05	6.17e-05	CcSEcCtD
Hydromorphone—Dermatitis—Etoposide—hematologic cancer	1.93e-05	6.17e-05	CcSEcCtD
Hydromorphone—Headache—Etoposide—hematologic cancer	1.92e-05	6.13e-05	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—hematologic cancer	1.92e-05	6.13e-05	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—hematologic cancer	1.92e-05	6.12e-05	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—hematologic cancer	1.92e-05	6.12e-05	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—hematologic cancer	1.92e-05	6.12e-05	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—hematologic cancer	1.91e-05	6.11e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Prednisone—hematologic cancer	1.91e-05	6.1e-05	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—hematologic cancer	1.91e-05	6.09e-05	CcSEcCtD
Hydromorphone—Rash—Prednisolone—hematologic cancer	1.91e-05	6.09e-05	CcSEcCtD
Hydromorphone—Dermatitis—Prednisolone—hematologic cancer	1.91e-05	6.08e-05	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.9e-05	6.08e-05	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—hematologic cancer	1.9e-05	6.06e-05	CcSEcCtD
Hydromorphone—Fatigue—Prednisone—hematologic cancer	1.9e-05	6.05e-05	CcSEcCtD
Hydromorphone—Headache—Prednisolone—hematologic cancer	1.9e-05	6.05e-05	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—hematologic cancer	1.89e-05	6.04e-05	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—hematologic cancer	1.89e-05	6.04e-05	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—hematologic cancer	1.89e-05	6.04e-05	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—hematologic cancer	1.89e-05	6.03e-05	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—hematologic cancer	1.89e-05	6.02e-05	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—hematologic cancer	1.89e-05	6.02e-05	CcSEcCtD
Hydromorphone—Constipation—Prednisone—hematologic cancer	1.88e-05	6e-05	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—hematologic cancer	1.87e-05	5.98e-05	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—hematologic cancer	1.86e-05	5.94e-05	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—hematologic cancer	1.85e-05	5.91e-05	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—hematologic cancer	1.85e-05	5.91e-05	CcSEcCtD
Hydromorphone—Dizziness—Triamcinolone—hematologic cancer	1.84e-05	5.87e-05	CcSEcCtD
Hydromorphone—Cough—Epirubicin—hematologic cancer	1.84e-05	5.87e-05	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—hematologic cancer	1.84e-05	5.86e-05	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—hematologic cancer	1.84e-05	5.86e-05	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—hematologic cancer	1.83e-05	5.83e-05	CcSEcCtD
Hydromorphone—Infection—Methotrexate—hematologic cancer	1.83e-05	5.83e-05	CcSEcCtD
Hydromorphone—Nausea—Etoposide—hematologic cancer	1.82e-05	5.82e-05	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—hematologic cancer	1.82e-05	5.81e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Prednisone—hematologic cancer	1.81e-05	5.78e-05	CcSEcCtD
Hydromorphone—Asthenia—Dexamethasone—hematologic cancer	1.81e-05	5.78e-05	CcSEcCtD
Hydromorphone—Asthenia—Betamethasone—hematologic cancer	1.81e-05	5.78e-05	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—hematologic cancer	1.81e-05	5.77e-05	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—hematologic cancer	1.8e-05	5.75e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Prednisone—hematologic cancer	1.8e-05	5.74e-05	CcSEcCtD
Hydromorphone—Nausea—Prednisolone—hematologic cancer	1.8e-05	5.74e-05	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—hematologic cancer	1.79e-05	5.73e-05	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—hematologic cancer	1.79e-05	5.73e-05	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—hematologic cancer	1.79e-05	5.73e-05	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—hematologic cancer	1.79e-05	5.72e-05	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—hematologic cancer	1.79e-05	5.71e-05	CcSEcCtD
Hydromorphone—Pruritus—Dexamethasone—hematologic cancer	1.79e-05	5.7e-05	CcSEcCtD
Hydromorphone—Pruritus—Betamethasone—hematologic cancer	1.79e-05	5.7e-05	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—hematologic cancer	1.78e-05	5.7e-05	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.78e-05	5.69e-05	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—hematologic cancer	1.78e-05	5.67e-05	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—hematologic cancer	1.77e-05	5.66e-05	CcSEcCtD
Hydromorphone—Vomiting—Triamcinolone—hematologic cancer	1.77e-05	5.65e-05	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—hematologic cancer	1.76e-05	5.61e-05	CcSEcCtD
Hydromorphone—Rash—Triamcinolone—hematologic cancer	1.75e-05	5.6e-05	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—hematologic cancer	1.75e-05	5.6e-05	CcSEcCtD
Hydromorphone—Dermatitis—Triamcinolone—hematologic cancer	1.75e-05	5.59e-05	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—hematologic cancer	1.75e-05	5.59e-05	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—hematologic cancer	1.75e-05	5.59e-05	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—hematologic cancer	1.75e-05	5.58e-05	CcSEcCtD
Hydromorphone—Urticaria—Prednisone—hematologic cancer	1.75e-05	5.57e-05	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—hematologic cancer	1.75e-05	5.57e-05	CcSEcCtD
Hydromorphone—Headache—Triamcinolone—hematologic cancer	1.74e-05	5.56e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Prednisone—hematologic cancer	1.74e-05	5.55e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Prednisone—hematologic cancer	1.74e-05	5.55e-05	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—hematologic cancer	1.73e-05	5.53e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Betamethasone—hematologic cancer	1.73e-05	5.51e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Dexamethasone—hematologic cancer	1.73e-05	5.51e-05	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—hematologic cancer	1.72e-05	5.5e-05	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—hematologic cancer	1.72e-05	5.49e-05	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—hematologic cancer	1.72e-05	5.48e-05	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—hematologic cancer	1.71e-05	5.47e-05	CcSEcCtD
Hydromorphone—Infection—Epirubicin—hematologic cancer	1.71e-05	5.45e-05	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—hematologic cancer	1.7e-05	5.43e-05	CcSEcCtD
Hydromorphone—Shock—Epirubicin—hematologic cancer	1.69e-05	5.4e-05	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—hematologic cancer	1.69e-05	5.39e-05	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—hematologic cancer	1.69e-05	5.38e-05	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—hematologic cancer	1.68e-05	5.37e-05	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—hematologic cancer	1.68e-05	5.36e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.67e-05	5.34e-05	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—hematologic cancer	1.67e-05	5.33e-05	CcSEcCtD
Hydromorphone—Dizziness—Betamethasone—hematologic cancer	1.67e-05	5.33e-05	CcSEcCtD
Hydromorphone—Dizziness—Dexamethasone—hematologic cancer	1.67e-05	5.33e-05	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—hematologic cancer	1.66e-05	5.31e-05	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—hematologic cancer	1.66e-05	5.3e-05	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—hematologic cancer	1.66e-05	5.3e-05	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—hematologic cancer	1.66e-05	5.3e-05	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—hematologic cancer	1.66e-05	5.3e-05	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—hematologic cancer	1.65e-05	5.28e-05	CcSEcCtD
Hydromorphone—Nausea—Triamcinolone—hematologic cancer	1.65e-05	5.27e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—hematologic cancer	1.65e-05	5.27e-05	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.65e-05	5.26e-05	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—hematologic cancer	1.64e-05	5.23e-05	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—hematologic cancer	1.64e-05	5.23e-05	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—hematologic cancer	1.64e-05	5.23e-05	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—hematologic cancer	1.63e-05	5.21e-05	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—hematologic cancer	1.62e-05	5.18e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Prednisone—hematologic cancer	1.62e-05	5.17e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—hematologic cancer	1.62e-05	5.16e-05	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—hematologic cancer	1.61e-05	5.13e-05	CcSEcCtD
Hydromorphone—Vomiting—Betamethasone—hematologic cancer	1.61e-05	5.12e-05	CcSEcCtD
Hydromorphone—Vomiting—Dexamethasone—hematologic cancer	1.61e-05	5.12e-05	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—hematologic cancer	1.6e-05	5.12e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—hematologic cancer	1.6e-05	5.1e-05	CcSEcCtD
Hydromorphone—Rash—Betamethasone—hematologic cancer	1.59e-05	5.08e-05	CcSEcCtD
Hydromorphone—Rash—Dexamethasone—hematologic cancer	1.59e-05	5.08e-05	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—hematologic cancer	1.59e-05	5.08e-05	CcSEcCtD
Hydromorphone—Dermatitis—Dexamethasone—hematologic cancer	1.59e-05	5.08e-05	CcSEcCtD
Hydromorphone—Dermatitis—Betamethasone—hematologic cancer	1.59e-05	5.08e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.59e-05	5.06e-05	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—hematologic cancer	1.58e-05	5.06e-05	CcSEcCtD
Hydromorphone—Headache—Dexamethasone—hematologic cancer	1.58e-05	5.05e-05	CcSEcCtD
Hydromorphone—Headache—Betamethasone—hematologic cancer	1.58e-05	5.05e-05	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—hematologic cancer	1.58e-05	5.05e-05	CcSEcCtD
Hydromorphone—Asthenia—Prednisone—hematologic cancer	1.58e-05	5.03e-05	CcSEcCtD
Hydromorphone—Pain—Methotrexate—hematologic cancer	1.57e-05	5.02e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.57e-05	5e-05	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—hematologic cancer	1.57e-05	5e-05	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—hematologic cancer	1.56e-05	4.98e-05	CcSEcCtD
Hydromorphone—Pruritus—Prednisone—hematologic cancer	1.56e-05	4.96e-05	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—hematologic cancer	1.56e-05	4.96e-05	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—hematologic cancer	1.55e-05	4.96e-05	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—hematologic cancer	1.55e-05	4.93e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—hematologic cancer	1.54e-05	4.93e-05	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.54e-05	4.91e-05	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—hematologic cancer	1.53e-05	4.89e-05	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—hematologic cancer	1.53e-05	4.88e-05	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—hematologic cancer	1.52e-05	4.84e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—hematologic cancer	1.51e-05	4.83e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—hematologic cancer	1.51e-05	4.83e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Prednisone—hematologic cancer	1.5e-05	4.8e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.5e-05	4.8e-05	CcSEcCtD
Hydromorphone—Nausea—Betamethasone—hematologic cancer	1.5e-05	4.79e-05	CcSEcCtD
Hydromorphone—Nausea—Dexamethasone—hematologic cancer	1.5e-05	4.79e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—hematologic cancer	1.49e-05	4.77e-05	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—hematologic cancer	1.49e-05	4.75e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.48e-05	4.74e-05	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—hematologic cancer	1.48e-05	4.73e-05	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—hematologic cancer	1.47e-05	4.69e-05	CcSEcCtD
Hydromorphone—Pain—Epirubicin—hematologic cancer	1.47e-05	4.69e-05	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—hematologic cancer	1.46e-05	4.66e-05	CcSEcCtD
Hydromorphone—Dizziness—Prednisone—hematologic cancer	1.45e-05	4.64e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—hematologic cancer	1.45e-05	4.64e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—hematologic cancer	1.45e-05	4.64e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.45e-05	4.63e-05	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—hematologic cancer	1.44e-05	4.59e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—hematologic cancer	1.43e-05	4.56e-05	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—hematologic cancer	1.42e-05	4.53e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—hematologic cancer	1.42e-05	4.52e-05	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—hematologic cancer	1.41e-05	4.51e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.41e-05	4.49e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—hematologic cancer	1.4e-05	4.47e-05	CcSEcCtD
Hydromorphone—Vomiting—Prednisone—hematologic cancer	1.4e-05	4.46e-05	CcSEcCtD
Hydromorphone—Rash—Prednisone—hematologic cancer	1.39e-05	4.42e-05	CcSEcCtD
Hydromorphone—Dermatitis—Prednisone—hematologic cancer	1.38e-05	4.42e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—hematologic cancer	1.38e-05	4.41e-05	CcSEcCtD
Hydromorphone—Headache—Prednisone—hematologic cancer	1.38e-05	4.4e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.37e-05	4.38e-05	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—hematologic cancer	1.37e-05	4.38e-05	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—hematologic cancer	1.37e-05	4.36e-05	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—hematologic cancer	1.36e-05	4.34e-05	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—hematologic cancer	1.36e-05	4.34e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—hematologic cancer	1.36e-05	4.34e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—hematologic cancer	1.36e-05	4.34e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—hematologic cancer	1.35e-05	4.32e-05	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—hematologic cancer	1.32e-05	4.21e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—hematologic cancer	1.31e-05	4.18e-05	CcSEcCtD
Hydromorphone—Nausea—Prednisone—hematologic cancer	1.31e-05	4.17e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.3e-05	4.15e-05	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—hematologic cancer	1.3e-05	4.15e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—hematologic cancer	1.27e-05	4.04e-05	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—hematologic cancer	1.26e-05	4.03e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—hematologic cancer	1.26e-05	4.01e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—hematologic cancer	1.26e-05	4.01e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—hematologic cancer	1.26e-05	4.01e-05	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—hematologic cancer	1.23e-05	3.94e-05	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—hematologic cancer	1.22e-05	3.88e-05	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—hematologic cancer	1.22e-05	3.88e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—hematologic cancer	1.18e-05	3.76e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—hematologic cancer	1.17e-05	3.74e-05	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—hematologic cancer	1.17e-05	3.73e-05	CcSEcCtD
Hydromorphone—Rash—Methotrexate—hematologic cancer	1.16e-05	3.7e-05	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—hematologic cancer	1.16e-05	3.69e-05	CcSEcCtD
Hydromorphone—Headache—Methotrexate—hematologic cancer	1.15e-05	3.67e-05	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—hematologic cancer	1.14e-05	3.64e-05	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—hematologic cancer	1.14e-05	3.63e-05	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—hematologic cancer	1.13e-05	3.59e-05	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—hematologic cancer	1.09e-05	3.49e-05	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—hematologic cancer	1.09e-05	3.48e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—hematologic cancer	1.09e-05	3.47e-05	CcSEcCtD
Hydromorphone—Rash—Epirubicin—hematologic cancer	1.08e-05	3.46e-05	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—hematologic cancer	1.08e-05	3.46e-05	CcSEcCtD
Hydromorphone—Headache—Epirubicin—hematologic cancer	1.08e-05	3.44e-05	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—hematologic cancer	1.05e-05	3.36e-05	CcSEcCtD
Hydromorphone—Nausea—Epirubicin—hematologic cancer	1.02e-05	3.26e-05	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—hematologic cancer	1.01e-05	3.23e-05	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—hematologic cancer	1e-05	3.2e-05	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—hematologic cancer	1e-05	3.2e-05	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—hematologic cancer	9.97e-06	3.18e-05	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—hematologic cancer	9.45e-06	3.02e-05	CcSEcCtD
Hydromorphone—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	7.1e-06	8.94e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	7.09e-06	8.93e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	7.07e-06	8.91e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ENO2—hematologic cancer	7.04e-06	8.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ENO2—hematologic cancer	6.98e-06	8.78e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FGF2—hematologic cancer	6.94e-06	8.73e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CREBBP—hematologic cancer	6.92e-06	8.72e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	6.92e-06	8.71e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TSC2—hematologic cancer	6.91e-06	8.71e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CREB1—hematologic cancer	6.88e-06	8.66e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	6.84e-06	8.61e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.83e-06	8.59e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—BRAF—hematologic cancer	6.79e-06	8.55e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—IDH2—hematologic cancer	6.77e-06	8.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMMR—hematologic cancer	6.77e-06	8.52e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.77e-06	8.52e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL2—hematologic cancer	6.73e-06	8.47e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6R—hematologic cancer	6.71e-06	8.45e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	6.7e-06	8.43e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SDC1—hematologic cancer	6.67e-06	8.4e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.66e-06	8.39e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	6.65e-06	8.37e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JAK2—hematologic cancer	6.65e-06	8.37e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SDC1—hematologic cancer	6.61e-06	8.33e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	6.59e-06	8.29e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CD—hematologic cancer	6.57e-06	8.27e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	6.52e-06	8.2e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MDM2—hematologic cancer	6.49e-06	8.17e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—hematologic cancer	6.48e-06	8.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ESR1—hematologic cancer	6.46e-06	8.13e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	6.39e-06	8.05e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.39e-06	8.04e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FN1—hematologic cancer	6.38e-06	8.03e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.36e-06	8.01e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	6.35e-06	8e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.32e-06	7.95e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MTOR—hematologic cancer	6.31e-06	7.95e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	6.31e-06	7.95e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BAD—hematologic cancer	6.31e-06	7.94e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	6.31e-06	7.94e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.29e-06	7.92e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	6.24e-06	7.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.24e-06	7.85e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	6.22e-06	7.83e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3R1—hematologic cancer	6.2e-06	7.81e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CA9—hematologic cancer	6.19e-06	7.79e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ACP5—hematologic cancer	6.19e-06	7.79e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CD80—hematologic cancer	6.12e-06	7.7e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.11e-06	7.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	6.11e-06	7.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KIT—hematologic cancer	6.11e-06	7.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	6.11e-06	7.69e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CG—hematologic cancer	6.09e-06	7.67e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FGF2—hematologic cancer	6.08e-06	7.66e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	6.03e-06	7.59e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	6e-06	7.55e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	6e-06	7.55e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.97e-06	7.51e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	5.93e-06	7.46e-05	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	5.86e-06	7.38e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	5.85e-06	7.36e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JAK2—hematologic cancer	5.83e-06	7.34e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—IDH1—hematologic cancer	5.82e-06	7.33e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CREB1—hematologic cancer	5.81e-06	7.32e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—hematologic cancer	5.81e-06	7.31e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—hematologic cancer	5.8e-06	7.3e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—hematologic cancer	5.77e-06	7.26e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TXN—hematologic cancer	5.76e-06	7.25e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.76e-06	7.25e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.76e-06	7.25e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BRAF—hematologic cancer	5.74e-06	7.23e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CB—hematologic cancer	5.72e-06	7.2e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	5.71e-06	7.19e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MDM2—hematologic cancer	5.69e-06	7.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL2—hematologic cancer	5.69e-06	7.16e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CD44—hematologic cancer	5.67e-06	7.14e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NQO1—hematologic cancer	5.67e-06	7.14e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6R—hematologic cancer	5.67e-06	7.14e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	5.66e-06	7.13e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—hematologic cancer	5.65e-06	7.12e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CREBBP—hematologic cancer	5.64e-06	7.11e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JUN—hematologic cancer	5.64e-06	7.1e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.63e-06	7.09e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NQO1—hematologic cancer	5.62e-06	7.08e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CD44—hematologic cancer	5.62e-06	7.08e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MTOR—hematologic cancer	5.54e-06	6.97e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	5.54e-06	6.97e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.51e-06	6.93e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	5.47e-06	6.88e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—hematologic cancer	5.46e-06	6.87e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.41e-06	6.81e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	5.4e-06	6.8e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	5.37e-06	6.76e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYCS—hematologic cancer	5.37e-06	6.76e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CD—hematologic cancer	5.35e-06	6.74e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	5.34e-06	6.72e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.33e-06	6.72e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	5.32e-06	6.7e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYCS—hematologic cancer	5.32e-06	6.7e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.32e-06	6.69e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.29e-06	6.66e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	5.29e-06	6.66e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—hematologic cancer	5.28e-06	6.65e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.26e-06	6.63e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.26e-06	6.63e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	5.26e-06	6.62e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EP300—hematologic cancer	5.2e-06	6.55e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	5.2e-06	6.54e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGF2—hematologic cancer	5.14e-06	6.47e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	5.14e-06	6.47e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.13e-06	6.46e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—hematologic cancer	5.09e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—hematologic cancer	5.08e-06	6.4e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	5.07e-06	6.38e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SRC—hematologic cancer	5.06e-06	6.37e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—hematologic cancer	5.06e-06	6.37e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3R1—hematologic cancer	5.05e-06	6.36e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NUP98—hematologic cancer	4.97e-06	6.26e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	4.96e-06	6.24e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JUN—hematologic cancer	4.95e-06	6.23e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—hematologic cancer	4.95e-06	6.23e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	4.93e-06	6.2e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JAK2—hematologic cancer	4.93e-06	6.2e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—hematologic cancer	4.88e-06	6.14e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NRAS—hematologic cancer	4.87e-06	6.13e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	4.83e-06	6.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.82e-06	6.07e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.82e-06	6.07e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MDM2—hematologic cancer	4.81e-06	6.06e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	4.8e-06	6.04e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NUP214—hematologic cancer	4.79e-06	6.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	4.78e-06	6.02e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.76e-06	5.99e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.73e-06	5.96e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—EP300—hematologic cancer	4.72e-06	5.94e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTR—hematologic cancer	4.69e-06	5.91e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.69e-06	5.91e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.69e-06	5.91e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	4.68e-06	5.89e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MTOR—hematologic cancer	4.68e-06	5.89e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	4.68e-06	5.89e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	4.67e-06	5.88e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.67e-06	5.87e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	4.66e-06	5.87e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ENO2—hematologic cancer	4.6e-06	5.79e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EP300—hematologic cancer	4.56e-06	5.74e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.54e-06	5.71e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—hematologic cancer	4.53e-06	5.71e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	4.52e-06	5.69e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.48e-06	5.64e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	4.47e-06	5.62e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.46e-06	5.62e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.44e-06	5.59e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SRC—hematologic cancer	4.44e-06	5.59e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	4.39e-06	5.53e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SDC1—hematologic cancer	4.36e-06	5.49e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.35e-06	5.47e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.35e-06	5.47e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	4.34e-06	5.47e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	4.32e-06	5.44e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.31e-06	5.43e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.31e-06	5.43e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—hematologic cancer	4.3e-06	5.42e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—hematologic cancer	4.3e-06	5.41e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	4.28e-06	5.39e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—hematologic cancer	4.28e-06	5.38e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	4.27e-06	5.37e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KRAS—hematologic cancer	4.19e-06	5.27e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—hematologic cancer	4.19e-06	5.27e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUN—hematologic cancer	4.18e-06	5.26e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	4.09e-06	5.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	4.05e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—hematologic cancer	4.04e-06	5.09e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—hematologic cancer	4.03e-06	5.08e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—hematologic cancer	3.98e-06	5.01e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	3.97e-06	4.99e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	3.96e-06	4.98e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	3.94e-06	4.97e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EP300—hematologic cancer	3.86e-06	4.85e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	3.85e-06	4.85e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—EP300—hematologic cancer	3.84e-06	4.84e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.84e-06	4.84e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.81e-06	4.8e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SRC—hematologic cancer	3.75e-06	4.72e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—hematologic cancer	3.72e-06	4.69e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NQO1—hematologic cancer	3.71e-06	4.67e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CD44—hematologic cancer	3.71e-06	4.67e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	3.67e-06	4.63e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	3.65e-06	4.6e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—hematologic cancer	3.62e-06	4.55e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NRAS—hematologic cancer	3.61e-06	4.54e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HRAS—hematologic cancer	3.56e-06	4.48e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYCS—hematologic cancer	3.51e-06	4.42e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—hematologic cancer	3.49e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.49e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	3.45e-06	4.35e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—hematologic cancer	3.41e-06	4.29e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	3.38e-06	4.25e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—hematologic cancer	3.36e-06	4.23e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.36e-06	4.23e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	3.35e-06	4.22e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—hematologic cancer	3.27e-06	4.11e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.23e-06	4.06e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.2e-06	4.03e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—hematologic cancer	3.14e-06	3.96e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	3.12e-06	3.93e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KRAS—hematologic cancer	3.1e-06	3.91e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.09e-06	3.89e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.99e-06	3.77e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—hematologic cancer	2.99e-06	3.76e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.97e-06	3.74e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.93e-06	3.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.85e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—hematologic cancer	2.85e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.84e-06	3.57e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.81e-06	3.54e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—hematologic cancer	2.8e-06	3.53e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—hematologic cancer	2.78e-06	3.5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—hematologic cancer	2.76e-06	3.47e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	2.76e-06	3.47e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.68e-06	3.37e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.66e-06	3.35e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HRAS—hematologic cancer	2.64e-06	3.32e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—hematologic cancer	2.53e-06	3.18e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.51e-06	3.16e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.47e-06	3.11e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.45e-06	3.09e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—hematologic cancer	2.33e-06	2.93e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—hematologic cancer	2.32e-06	2.92e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—hematologic cancer	2.14e-06	2.69e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—hematologic cancer	2.12e-06	2.67e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.11e-06	2.66e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—EP300—hematologic cancer	2.04e-06	2.57e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—EP300—hematologic cancer	2.02e-06	2.54e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.96e-06	2.46e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.86e-06	2.34e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—hematologic cancer	1.83e-06	2.31e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.75e-06	2.21e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.62e-06	2.04e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.5e-06	1.88e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.4e-06	1.76e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—EP300—hematologic cancer	1.33e-06	1.68e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.23e-06	1.55e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.86e-07	1.24e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—hematologic cancer	8.05e-07	1.01e-05	CbGpPWpGaD
